Scope Fluidics achieves second EDOCERA milestone, gets green light for next phase

Polish biotech Scope Fluidics announced it has met the second goal in its EDOCERA project and received approval to proceed. The announcement is thin on specifics, so the technical and commercial significance remains unclear. This is a routine corporate progress update for a specialized diagnostics developer, with no immediate market-wide implications.